Medicon Valley Alliance News

Medicon Valley Alliance Newshttp://www.mva.orgMVA Newsen-usmva@mva.orgClinical Trials Update - Week 19, 2008http://www.mva.org/composite-3139.htm 2008-05-09T00:00:003139New Scientific Advisors will shape the scientific tools of tomorrowhttp://www.mva.org/composite-3134.htm 2008-05-09T00:00:003134SensoDetect Gets More Venture Capital (in Danish)http://www.mva.org/composite-3138.htm 2008-05-09T00:00:003138The Nordic Health Care Industry to Share Experience Cross Companieshttp://www.mva.org/composite-3131.htm 2008-05-08T00:00:003131ViroGates Enters Into a Long-Term Research Collaboration with Hvidovre Hospitalhttp://www.mva.org/composite-3133.htm 2008-05-08T00:00:003133Zymenex Hosts European Alpha-mannosidosis Disease Group Meetinghttp://www.mva.org/composite-3132.htm 2008-05-07T00:00:003132People on the Move: Novo Nordisk Researchers Nominated for Europe's Top Innovation Prizehttp://www.mva.org/composite-3117.htm 2008-05-06T00:00:003117Pharma's Pipeline is Dependent on Biotech (in Danish)http://www.mva.org/composite-3129.htm 2008-05-06T00:00:003129Øresundsinstituttet: Invest in Sweden Agency Cries Wolf about Swedish and Danish Competitivenesshttp://www.mva.org/composite-3127.htm 2008-05-05T00:00:003127AstraZeneca Submits sNDA for SYMBICORT® for COPD Treatmenthttp://www.mva.org/composite-3126.htm 2008-05-03T00:00:003126BioGaia in Strategic Alliance with BERICAPhttp://www.mva.org/composite-3125.htm 2008-05-02T00:00:003125Clinical Trials Update, Week 18, 2008http://www.mva.org/composite-3119.htm 2008-05-02T00:00:003119EU Plans for Improved Patient Information (in Danish)http://www.mva.org/composite-3124.htm 2008-05-01T00:00:003124Bridge-BSR Plans for New Financing Network for Biotechhttp://www.mva.org/composite-3123.htm 2008-04-30T00:00:003123Encorium Group, Inc. Expands its European Operationshttp://www.mva.org/composite-3122.htm 2008-04-29T00:00:003122Novo Nordisk Donation Aids Chinese Pharmaceutical Development and WHOhttp://www.mva.org/composite-3116.htm 2008-04-28T00:00:003116BioInvent Buys Cancer Research from Angiogenetics (in Swedish)http://www.mva.org/composite-3115.htm 2008-04-28T00:00:003115Zymenex Sells Phase II Drug Candidate for USD 135 Millions (in Danish)http://www.mva.org/composite-3112.htm 2008-04-25T00:00:003112Clinical Trials Update, Week 17, 2008http://www.mva.org/composite-3111.htm 2008-04-25T00:00:003111MPI Selects Insightful Corporation for Predictive Analytics and Reportinghttp://www.mva.org/composite-3109.htm 2008-04-24T00:00:003109BioGaia Signs Agreement for Belgium and Luxembourghttp://www.mva.org/composite-3108.htm 2008-04-24T00:00:003108TopoTarget Successfully Buys Back Full Control of Belinostathttp://www.mva.org/composite-3107.htm 2008-04-23T00:00:003107NatImmune Initiates Clinical Phase IIb Trial (in Danish)http://www.mva.org/composite-3105.htm 2008-04-22T00:00:003105Denmark to Have a New DNA Registerhttp://www.mva.org/composite-3104.htm 2008-04-22T00:00:003104Awapatent Restructures in Four Swedish Officeshttp://www.mva.org/composite-3099.htm 2008-04-21T00:00:003099Commission Cuts Unnecessary Administrative Burdens in EU Company Lawhttp://www.mva.org/composite-3096.htm 2008-04-17T00:00:003096Clinical Trials Update - Week 16, 2008http://www.mva.org/composite-3095.htm 2008-04-17T00:00:003095ESS Scandinavia Focus on Pro-Environmental Energy Solutionhttp://www.mva.org/composite-3087.htm 2008-04-15T00:00:003087Millions for Biotech in Danish High Schoolshttp://www.mva.org/composite-3080.htm 2008-04-15T00:00:003080Commitum New Company of the Year in Lundhttp://www.mva.org/composite-3074.htm 2008-04-14T00:00:003074MIP Technologies and Supelco Launch New SPE Applicationhttp://www.mva.org/composite-3078.htm 2008-04-14T00:00:003078SEK 40 Million in Bioimaging Fundshttp://www.mva.org/composite-3073.htm 2008-04-11T00:00:003073TFS Established its First Office in Cambridge (MA), United Stateshttp://www.mva.org/composite-3072.htm 2008-04-11T00:00:003072MVA Newsletter, no. 4, April 2008http://www.mva.org/composite-3070.htm 2008-04-10T00:00:003070Clinical Trials Update - Week 15, 2008http://www.mva.org/composite-3066.htm 2008-04-10T00:00:003066NsGene's Alzheimer's Product Successfully Implanted in Patientshttp://www.mva.org/composite-3065.htm 2008-04-10T00:00:003065Rechon Life Science Aims at Creating New Jobs in Limhamn (in Swedish)http://www.mva.org/composite-3053.htm 2008-04-10T00:00:003053Nature Publishes New Scientific Results from Lund University Regarding Parkinson’s (in Swedish)http://www.mva.org/composite-3058.htm 2008-04-09T00:00:003058ESS Siting in Lund Formally Supported by Danish Governmenthttp://www.mva.org/composite-3043.htm 2008-04-08T00:00:003043Vakuum efter projekt som gav 400 forretningskontakter over Sundet (in Danish)http://www.mva.org/composite-3046.htm 2008-04-08T00:00:003046Active Biotech AB Heads for a Guaranteed Rights Issue of SEK 160 Millionshttp://www.mva.org/composite-3044.htm 2008-04-08T00:00:003044Nordic Life Science Review 2008: Another Great Year in Medicon Valleyhttp://www.mva.org/composite-3041.htm 2008-04-07T00:00:003041New Positions within Healthcare Science Unites Universities and Hospitals (in Swedish)http://www.mva.org/composite-3036.htm 2008-04-04T00:00:003036Clinical Trials Update - Week 14, 2008http://www.mva.org/composite-3034.htm 2008-04-04T00:00:003034Eurostars Needs Qualified Reviewers (in Danish)http://www.mva.org/composite-3032.htm 2008-04-03T00:00:003032Novo Seeds Invests in MycoTeQ (in Danish)http://www.mva.org/composite-3033.htm 2008-04-02T00:00:003033Great Differences between Danish and Swedish Negotiation Culture (in Danish)http://www.mva.org/composite-3022.htm 2008-03-28T00:00:003022Nature Publishes Santaris Pharma Study on microRNA Silencinghttp://www.mva.org/composite-3025.htm 2008-03-27T00:00:003025CellaVision AB Establishes Subsidiary in Japanhttp://www.mva.org/composite-3026.htm 2008-03-27T00:00:003026Drastic Change in Research Fundinghttp://www.mva.org/composite-3023.htm 2008-03-26T00:00:003023LU Bioscience: Capital and Personnel Now in Place (In Danish)http://www.mva.org/composite-3021.htm 2008-03-21T00:00:003021Export of Danish Medicine Have Reached DKK 40 Billionhttp://www.mva.org/composite-3011.htm 2008-03-20T00:00:003011Science Parks Calls for Additional Start-up Funding (in Danish)http://www.mva.org/composite-3014.htm 2008-03-20T00:00:003014Clinical Trials Update - Week 12, 2008http://www.mva.org/composite-3008.htm 2008-03-19T00:00:003008Lund University: New Weapon against Autoimmune Diseases (in Swedish)http://www.mva.org/composite-3012.htm 2008-03-19T00:00:003012Camurus and DiObex Enters License Agreement Regarding Insulin-induced Hypoglycemia in Diabeteshttp://www.mva.org/composite-3010.htm 2008-03-18T00:00:003010MPI Launches DNA Microarray Serviceshttp://www.mva.org/composite-2996.htm 2008-03-18T00:00:002996European Innovation Gets Institutehttp://www.mva.org/composite-3005.htm 2008-03-17T00:00:003005BioInvent Signs Deal with Bayer HealthCarehttp://www.mva.org/composite-3004.htm 2008-03-17T00:00:003004Novozymes Doubles its Capacity in Lund (in Swedish)http://www.mva.org/composite-3003.htm 2008-03-17T00:00:003003MVA Newsletter no. 3, March 2008http://www.mva.org/composite-3002.htm 2008-03-14T00:00:003002Exchanging Medicon Valley-US Experiences at the Health Care Innovation Week in Washington DChttp://www.mva.org/composite-3000.htm 2008-03-14T00:00:003000The Citizens Around Øresund Deserves a Better Press Coverage of the Region (in Danish)http://www.mva.org/composite-2997.htm 2008-03-14T00:00:002997FDA Ponders Stricter Rules for Diabetes Drugshttp://www.mva.org/composite-2982.htm 2008-03-12T00:00:002982Virus Cause Type 1 Diabetes: New Evidence from LUDChttp://www.mva.org/composite-2989.htm 2008-03-12T00:00:002989LifeAssays: Distribution Agreement with Finnish POC Distributor (in Swedish)http://www.mva.org/composite-2983.htm 2008-03-12T00:00:002983The Future of Danish National Research Foundation Secured (in Danish)http://www.mva.org/composite-2984.htm 2008-03-11T00:00:002984Genovis Signs Distribution Deal with Nordic Biolabshttp://www.mva.org/composite-2980.htm 2008-03-11T00:00:002980Medicon Valley: An Example of a Best Practice Clusterhttp://www.mva.org/composite-2999.htm 2008-03-10T00:00:002999Genmab and Pepscan to Identify Human Antibodieshttp://www.mva.org/composite-2981.htm 2008-03-10T00:00:002981Clinical Trials Update - Week 10, 2008http://www.mva.org/composite-2979.htm 2008-03-07T00:00:002979Symphogen Issued Patent Covering Symplex Technologyhttp://www.mva.org/composite-2976.htm 2008-03-07T00:00:002976Lund University Awards Three with Honorary Doctorateshttp://www.mva.org/composite-2977.htm 2008-03-07T00:00:002977Ferring Pharmaceuticals: New Drug Application for Degarelixhttp://www.mva.org/composite-2970.htm 2008-03-05T00:00:002970Application Deadline: The National Programme for Research Infrastructurehttp://www.mva.org/composite-2971.htm 2008-03-05T00:00:002971ALK Abelló Announces Positive Third Year Results from Clinical Study with GRAZAXhttp://www.mva.org/composite-2969.htm 2008-03-04T00:00:002969Clinical Trials Update - Week 9, 2008http://www.mva.org/composite-2963.htm 2008-02-29T00:00:002963Biotech Still Profitable (in Danish)http://www.mva.org/composite-2964.htm 2008-02-28T00:00:002964TopoTarget's APO010 Patent Allowed in the UShttp://www.mva.org/composite-2962.htm 2008-02-28T00:00:002962Green Health Care: Creating Hospitals for the Future in Medicon Valleyhttp://www.mva.org/composite-2959.htm 2008-02-27T00:00:002959Øresund Science Region: Number One in the EU RegioStars Awardhttp://www.mva.org/composite-2958.htm 2008-02-26T00:00:002958VINN NU 2008: Application Deadline 3 March 2008http://www.mva.org/composite-2953.htm 2008-02-25T00:00:002953Novo Nordisk Prize 2008 to BRIC Directorhttp://www.mva.org/composite-2947.htm 2008-02-23T00:00:002947BioGaia Signs New Agreement with Ferring Pharmaceuticalshttp://www.mva.org/composite-2950.htm 2008-02-22T00:00:002950Clinical Trials Update - Week 8, 2008http://www.mva.org/composite-2944.htm 2008-02-22T00:00:002944Sunstone Capital to Invest in Six Big Companies in the Øresund Region in 2008http://www.mva.org/composite-2946.htm 2008-02-21T00:00:002946Ambitious Health Goals are Life Saving in People with Type 2 Diabeteshttp://www.mva.org/composite-2942.htm 2008-02-20T00:00:002942Forska&Väx: SEK 100 million to SMEs in Swedenhttp://www.mva.org/composite-2928.htm 2008-02-18T00:00:002928New EU-Office to make the Capital Region a Leading Science Regionhttp://www.mva.org/composite-2927.htm 2008-02-18T00:00:002927AstraZeneca Creates new Company in Gothenburghttp://www.mva.org/composite-2929.htm 2008-02-18T00:00:002929Exini Cleared in Canadahttp://www.mva.org/composite-2925.htm 2008-02-18T00:00:002925The Biotech Bubble Bursts: Investments to Normalizehttp://www.mva.org/composite-2923.htm 2008-02-18T00:00:002923CellaVision sees Increased Resultshttp://www.mva.org/composite-2926.htm 2008-02-18T00:00:002926Clinical Trials Update - Week 7, 2008http://www.mva.org/composite-2919.htm 2008-02-15T00:00:002919ESS: Nordic-Baltic Cooperation on Track to Start Construction in 2010http://www.mva.org/composite-2922.htm 2008-02-15T00:00:002922MVA Newsletter, no 2, February 2008http://www.mva.org/composite-2918.htm 2008-02-14T00:00:002918Nordic-Baltic Alliance to bring ESS to Lund (in Danish)http://www.mva.org/composite-2909.htm 2008-02-12T00:00:002909SMEs to Compete with SEK 60 Millionhttp://www.mva.org/composite-2911.htm 2008-02-12T00:00:002911Clinical Trials Update - Week 6, 2008http://www.mva.org/composite-2885.htm 2008-02-08T00:00:002885Funding Opportunities for an Industry PhD or Industry Researcher (IFA). Deadline 15 Aprilhttp://www.mva.org/composite-2900.htm 2008-02-07T00:00:002900Nordic Biotech Mergers on the Way (in Danish)http://www.mva.org/composite-2908.htm 2008-02-06T00:00:002908University Hospitals in Skåne: Two Profiles, One Unithttp://www.mva.org/composite-2899.htm 2008-02-06T00:00:002899Partnerring opportunities in the CBS MBA Strategy Projecthttp://www.mva.org/composite-2898.htm 2008-02-06T00:00:002898Small Business Act: The European Commission’s Commitment to SME'shttp://www.mva.org/composite-2897.htm 2008-02-06T00:00:002897Revolutionary Results from Lund University Regarding Asthma (in Swedish)http://www.mva.org/composite-2912.htm 2008-02-05T00:00:002912Danish Biotech Heading Towards a Fire Sale (in Danish)http://www.mva.org/composite-2894.htm 2008-01-31T00:00:002894QPharma Invests Millions in a New Production Line in Malmö (in Danish)http://www.mva.org/composite-2891.htm 2008-01-30T00:00:002891Scandinavia's Life Science Growth Enginehttp://www.mva.org/composite-2886.htm 2008-01-28T00:00:002886Clinical Trials Update - Week 4, 2008http://www.mva.org/composite-2876.htm 2008-01-25T00:00:002876Swedes and Danes are Crazy for Research Newshttp://www.mva.org/composite-2884.htm 2008-01-25T00:00:002884Sunstone Capital Crosses Oresundhttp://www.mva.org/composite-2883.htm 2008-01-25T00:00:002883Action Pharma Raises EUR 15 Million from International Investorshttp://www.mva.org/composite-2881.htm 2008-01-24T00:00:002881Venture Cup Research Challenge - Application Deadline 12 Februaryhttp://www.mva.org/composite-2877.htm 2008-01-22T00:00:002877The First Pre-seed Grant From Novo Seeds Awardedhttp://www.mva.org/composite-2873.htm 2008-01-22T00:00:002873Innovation Team Completes Development of New Monitoring System for Redsense Medical ABhttp://www.mva.org/composite-2872.htm 2008-01-21T00:00:002872Clinical Trials Update - Week 3, 2008http://www.mva.org/composite-2856.htm 2008-01-18T00:00:002856MVA Newsletter, no. 1, January 2008http://www.mva.org/composite-2871.htm 2008-01-18T00:00:002871A New Piece Added to the Diabetes Puzzle by Lund University Diabetes Centerhttp://www.mva.org/composite-2867.htm 2008-01-17T00:00:002867EuroBioFund Call for Expressions of Interesthttp://www.mva.org/composite-2859.htm 2008-01-16T00:00:002859The Pace of Danish Biotech Leaves the Rest of Europe Trailinghttp://www.mva.org/composite-2862.htm 2008-01-16T00:00:002862Hansa Medical Buys Patents and Properties from Cartela (in Swedish)http://www.mva.org/composite-2853.htm 2008-01-15T00:00:002853TopoTarget's Savene Recommended as Standard Treatment for Anthracycline Extravasation.http://www.mva.org/composite-2857.htm 2008-01-15T00:00:002857Novo Nordisk Refocuses its Activities within Inhaled Insulinhttp://www.mva.org/composite-2861.htm 2008-01-15T00:00:002861Former Nycomed Executive Acquires KLIFOhttp://www.mva.org/composite-2846.htm 2008-01-11T00:00:002846Clinical Trials Update - Week 2, 2008http://www.mva.org/composite-2841.htm 2008-01-11T00:00:002841BioGaia Signs Global Agreement for Oral Health Productshttp://www.mva.org/composite-2840.htm 2008-01-11T00:00:002840MIP Technologies and Supelco Launch a New Selective SPE Producthttp://www.mva.org/composite-2838.htm 2008-01-10T00:00:0028382007 an Excellent Year for Danish Biotechhttp://www.mva.org/composite-2835.htm 2008-01-10T00:00:002835ViroGates Introduces a Life-saver to the European Markethttp://www.mva.org/composite-2834.htm 2008-01-08T00:00:002834Ascendis Pharma A/S has Completed its first-round of Venture Capital Financing and Acquired Complex Biosystems GmbHhttp://www.mva.org/composite-2831.htm 2008-01-07T00:00:002831Big Pharma Courts in Medicon Valleyhttp://www.mva.org/composite-2855.htm 2008-01-03T00:00:002855Science Magazine: Breakthrough of the Year with Participation from Lund University (in Swedish)http://www.mva.org/composite-2850.htm 2007-12-21T00:00:002850Clinical Trials Update - Week 51, 2007http://www.mva.org/composite-2828.htm 2007-12-21T00:00:002828Top News About IMI: EU Adopts Innovative Medicines Initiativehttp://www.mva.org/composite-2827.htm 2007-12-21T00:00:002827EU Commission Signs with ScanBalt to Support SME'shttp://www.mva.org/composite-2825.htm 2007-12-21T00:00:002825GlaxoSmithKline and Santaris Pharma Enter Global R&D Alliancehttp://www.mva.org/composite-2823.htm 2007-12-21T00:00:002823MVA Newsletter no. 12, December 2007http://www.mva.org/composite-2821.htm 2007-12-20T00:00:002821Novo Nordisk Licenses Global Rights to Potential New Haemostasis Therapyhttp://www.mva.org/composite-2818.htm 2007-12-19T00:00:002818Santaris Pharma Raises €20 Million of New Equityhttp://www.mva.org/composite-2817.htm 2007-12-18T00:00:002817Cartela goes Bankrupt (in Danish)http://www.mva.org/composite-2816.htm 2007-12-17T00:00:002816Danish Biotech at a Crossroadshttp://www.mva.org/composite-2815.htm 2007-12-17T00:00:002815Innovative Medicines Initiative Expected to Start in January 2008http://www.mva.org/composite-2813.htm 2007-12-14T00:00:002813Clinical Trials Update - Week 50, 2007http://www.mva.org/composite-2811.htm 2007-12-13T00:00:002811New Improved Diagnostic Marker for Severe Blood Cancerhttp://www.mva.org/composite-2808.htm 2007-12-12T00:00:002808Clinical Trials Update - Week 49, 2007http://www.mva.org/composite-2803.htm 2007-12-05T00:00:002803Eva Steiness Leaves Zealand Pharma (in Danish)http://www.mva.org/composite-2799.htm 2007-12-03T00:00:002799Sweden in Top Position Regarding Innovation Capacityhttp://www.mva.org/composite-2800.htm 2007-12-03T00:00:002800Øresundsregionen som forskermagnet (in Danish)http://www.mva.org/composite-2795.htm 2007-11-30T00:00:002795Clinical Trials Update - Week 48, 2007http://www.mva.org/composite-2764.htm 2007-11-29T00:00:002764Broadening Competences in Drug Developmenthttp://www.mva.org/composite-2779.htm 2007-11-29T00:00:002779EU Commision Study: Pharmaceuticals One of Europe's Most Competitive Manufacturing Sectorshttp://www.mva.org/composite-2776.htm 2007-11-27T00:00:002776IFA project at MIP Technologies co-funded by the Swedish Research Councilhttp://www.mva.org/composite-2775.htm 2007-11-26T00:00:002775Svenskerne parate til at jobbe i Danmark (in Danish)http://www.mva.org/composite-2774.htm 2007-11-26T00:00:002774AstraZeneca Receives FDA Approval for Maintenance Treatment of Schizophreniahttp://www.mva.org/composite-2773.htm 2007-11-23T00:00:002773Entrepreneur Of The Year: Symphogen A/S is the Best Biotech Company in Denmark 2007 (in Danish)http://www.mva.org/composite-2771.htm 2007-11-23T00:00:002771ScanBalt BioRegion to Collaborate on Cancerhttp://www.mva.org/composite-2769.htm 2007-11-22T00:00:002769Clinical Trials Update - Week 47http://www.mva.org/composite-2747.htm 2007-11-22T00:00:002747FDA Grants Approval to AstraZenecahttp://www.mva.org/composite-2762.htm 2007-11-21T00:00:002762Alligator Bioscience Strengthens its FIND® Patent Portfoliohttp://www.mva.org/composite-2761.htm 2007-11-19T00:00:002761New Innovation House at Lund Universityhttp://www.mva.org/composite-2760.htm 2007-11-19T00:00:002760MVA Newsletter no. 11, November 2007http://www.mva.org/composite-2758.htm 2007-11-16T00:00:002758MVA Members Meet the First Life Science Ambassadorhttp://www.mva.org/composite-2748.htm 2007-11-16T00:00:002748Notion of an ‘Open-Source' Database Awarded 1st Prizehttp://www.mva.org/composite-2749.htm 2007-11-15T00:00:002749First Statin Clinical Trial Resultshttp://www.mva.org/composite-2746.htm 2007-11-13T00:00:002746SEK 323 Million for Medical Researchhttp://www.mva.org/composite-2744.htm 2007-11-13T00:00:002744New SAMPOST Application Deadline (in Swedish)http://www.mva.org/composite-2745.htm 2007-11-12T00:00:002745Clinical Trials Update - Week 45http://www.mva.org/composite-2729.htm 2007-11-07T00:00:002729Nycomed Strengthens US Dermatology Businesshttp://www.mva.org/composite-2740.htm 2007-11-06T00:00:002740Medicon Valley to Become Life Science Hub (in Danish)http://www.mva.org/composite-2757.htm 2007-11-03T00:00:002757Novozymes to Acquire Philom Bios Inc., Canadahttp://www.mva.org/composite-2735.htm 2007-11-02T00:00:002735MVA 10-Year Jubilee - A Sum-Up of the Programmehttp://www.mva.org/composite-2751.htm 2007-11-01T00:00:002751Denmark and Sweden ranked 3rd and 4th in the Global Competitiveness Index 2007http://www.mva.org/composite-2732.htm 2007-11-01T00:00:002732Effective Networking and Socialising at the MVA 10-year Jubileehttp://www.mva.org/composite-2752.htm 2007-11-01T00:00:002752Student from Sorø Akademis Skole Wins the Medicon Valley Life Science Essay Competitionhttp://www.mva.org/composite-2731.htm 2007-11-01T00:00:002731Commercial Collaboration Agreement between Harrison Clinical Research and Cyncronhttp://www.mva.org/composite-2730.htm 2007-11-01T00:00:002730New Issue of Stocks Can Save ErySavehttp://www.mva.org/composite-2726.htm 2007-10-26T00:00:002726Mitelman Wins Nordic Fernström Prizehttp://www.mva.org/composite-2724.htm 2007-10-22T00:00:002724Genovis Launches US Operation, Recruits American Managerhttp://www.mva.org/composite-2719.htm 2007-10-19T00:00:002719SKAPA Award 2007http://www.mva.org/composite-2717.htm 2007-10-18T00:00:002717NNIT in Medicine Researchhttp://www.mva.org/composite-2709.htm 2007-10-17T00:00:002709Clinical Trials Update - Week 42http://www.mva.org/composite-2705.htm 2007-10-15T00:00:002705Genmab’s HuMax-CD4 Displays Unique Mechanism of Actionhttp://www.mva.org/composite-2700.htm 2007-10-15T00:00:002700New Life Science Fund Established in Lund (in Danish)http://www.mva.org/composite-2698.htm 2007-10-15T00:00:002698MVA Newsletter no. 10, October 2007http://www.mva.org/composite-2695.htm 2007-10-10T00:00:002695International Affairs are Happening in Medicon Valleyhttp://www.mva.org/composite-2759.htm 2007-10-10T00:00:002759Medicon Valley Life Science Tour and Competitionhttp://www.mva.org/composite-2694.htm 2007-10-10T00:00:002694TopoTarget Ready To Launch Totect in the UShttp://www.mva.org/composite-2693.htm 2007-10-10T00:00:002693Recipharm wins Best Contract Manufacturing Project Awardhttp://www.mva.org/composite-2710.htm 2007-10-06T00:00:002710TopoTarget and Lundbeck Sign Agreement for Siramesinehttp://www.mva.org/composite-2708.htm 2007-10-05T00:00:002708Clinical Trials Update - Week 40http://www.mva.org/composite-2676.htm 2007-10-05T00:00:002676US Government Extends RFP-2 Contract with Bavarian Nordichttp://www.mva.org/composite-2688.htm 2007-10-04T00:00:002688Novozymes on Sustainable Business 20 Listhttp://www.mva.org/composite-2685.htm 2007-10-02T00:00:002685High Level of Scientific Research in Medicon Valleyhttp://www.mva.org/composite-2681.htm 2007-10-01T00:00:002681New Anti-Diabetic Food Centre at Lund Universityhttp://www.mva.org/composite-2683.htm 2007-10-01T00:00:002683Upfront Chromatography Closes Investment Fundinghttp://www.mva.org/composite-2675.htm 2007-09-28T00:00:002675Probi AB Agreement Opens American Market for Health Foodshttp://www.mva.org/composite-2673.htm 2007-09-28T00:00:002673ACADIA Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Indexhttp://www.mva.org/composite-2679.htm 2007-09-27T00:00:002679Lundbeck in-licenses Circadinhttp://www.mva.org/composite-2674.htm 2007-09-27T00:00:002674Easier Way To New Pharmaceuticalshttp://www.mva.org/composite-2672.htm 2007-09-27T00:00:002672EU Money to Stroke Research in Lundhttp://www.mva.org/composite-2671.htm 2007-09-26T00:00:002671Nordic Venture Summit - a News Updatehttp://www.mva.org/composite-2669.htm 2007-09-25T00:00:002669Local Treatment of Prostate Cancer to Reduce Side Effects is the Aim for LIDDS (in Swedish)http://www.mva.org/composite-2667.htm 2007-09-21T00:00:002667ViroGates Changes Management and Board Structurehttp://www.mva.org/composite-2668.htm 2007-09-20T00:00:002668New Method for Control of Bacterias (in Swedish)http://www.mva.org/composite-2666.htm 2007-09-20T00:00:002666Danish Scientist Awarded 1st Prize for Researchhttp://www.mva.org/composite-2663.htm 2007-09-18T00:00:002663Clinical Trials Update - Week 38http://www.mva.org/composite-2662.htm 2007-09-18T00:00:002662Gene Logic Collaborates with FDAhttp://www.mva.org/composite-2686.htm 2007-09-14T00:00:002686Novo Nordisk is Rated Supersector Leaderhttp://www.mva.org/composite-2653.htm 2007-09-14T00:00:002653Topotarget's Totect approved in the UShttp://www.mva.org/composite-2648.htm 2007-09-12T00:00:002648MVA Newsletter no. 09, September 2007http://www.mva.org/composite-2647.htm 2007-09-11T00:00:002647Guidance could improve success rate in EU HEALTH callshttp://www.mva.org/composite-2644.htm 2007-09-11T00:00:002644Clinical Trials Update - Week 37http://www.mva.org/composite-2640.htm 2007-09-10T00:00:002640Lundbeck and Takeda form strategic alliancehttp://www.mva.org/composite-2643.htm 2007-09-07T00:00:002643Topotarget and Pharmexa expect lucrative deals with big pharma (in Danish)http://www.mva.org/composite-2641.htm 2007-09-06T00:00:002641New staff appointed to ESS secretariathttp://www.mva.org/composite-2635.htm 2007-08-30T00:00:0026352009: Biotech Boom in Medicon Valleyhttp://www.mva.org/composite-2632.htm 2007-08-27T00:00:002632Business Week: Medicon Valley leads biotech growthhttp://www.mva.org/composite-2624.htm 2007-08-22T00:00:002624Clinical Trials Update - Week 34http://www.mva.org/composite-2608.htm 2007-08-21T00:00:002608VINNOVA: Swedish application deadlines (in Swedish)http://www.mva.org/composite-2619.htm 2007-08-21T00:00:002619University of Copenhagen no. 8 in Europehttp://www.mva.org/composite-2620.htm 2007-08-20T00:00:002620Danish joy and Swedish complaints about public research fundinghttp://www.mva.org/composite-2618.htm 2007-08-20T00:00:002618Danish biotech shares on course for greater heights (in Danish)http://www.mva.org/composite-2616.htm 2007-08-16T00:00:002616Novo Nordisk is the future winner in the global pharmaceutical markethttp://www.mva.org/composite-2609.htm 2007-08-14T00:00:002609The Medicon Valley region: A great biotech successhttp://www.mva.org/composite-2610.htm 2007-08-14T00:00:002610MVA Newsletter no. 08, August 2007http://www.mva.org/composite-2605.htm 2007-08-14T00:00:002605Participation in first EU HEALTH call meets with great successhttp://www.mva.org/composite-2602.htm 2007-08-13T00:00:002602Clinical Trials Update - Week 32http://www.mva.org/composite-2597.htm 2007-08-08T00:00:002597Millions for Danish allergy research (in Danish)http://www.mva.org/composite-2599.htm 2007-08-08T00:00:002599Sweden is the solution to Danish recruiting problems (in Danish)http://www.mva.org/composite-2592.htm 2007-08-07T00:00:002592EUR 35 million to attract researchers to Denmarkhttp://www.mva.org/composite-2585.htm 2007-08-02T00:00:002585EMEA grants orphan drug status to Active Biotech and Astion Pharma productshttp://www.mva.org/composite-2582.htm 2007-08-02T00:00:002582ViroGates closes new financing round with successful exit for seed investorhttp://www.mva.org/composite-2581.htm 2007-08-02T00:00:002581OECD: Danish hospital system is one of the world's most efficienthttp://www.mva.org/composite-2583.htm 2007-08-01T00:00:002583MVA Newsletter no. 07, July 2007http://www.mva.org/composite-2572.htm 2007-07-06T00:00:002572BioInvent implements a directed new share issue worth SEK 125 millionhttp://www.mva.org/composite-2574.htm 2007-07-06T00:00:002574Santaris Pharma awarded DKK 10 million for development of the first microRNA medicinehttp://www.mva.org/composite-2570.htm 2007-07-04T00:00:002570Five health related projects funded by Højteknologifonden (in Danish)http://www.mva.org/composite-2567.htm 2007-07-04T00:00:002567A portray of the Strictly Financing Award 2007 winnerhttp://www.mva.org/composite-2545.htm 2007-06-25T00:00:002545British investors keep an eye on Medicon Valley biotechhttp://www.mva.org/composite-2544.htm 2007-06-25T00:00:002544Michael Oredsson appointed CEO of Probi ABhttp://www.mva.org/composite-1065.htm 2007-06-14T00:00:001065Camurus AB selected the best private biotech company in Medicon Valley 2007http://www.mva.org/composite-1125.htm 2007-06-13T00:00:001125Active Biotech and Teva initiates pivotal phase III trialhttp://www.mva.org/composite-1124.htm 2007-06-08T00:00:001124Santaris Pharma presents positive clinical data on SPC2996 in Chronic Lymphocytic Leukaemiahttp://www.mva.org/composite-1123.htm 2007-06-08T00:00:001123Genmab’s HuMax-EGFr Shows Broad Potential in Cancer Treatmenthttp://www.mva.org/composite-1120.htm 2007-06-07T00:00:001120Exclusive contract to Bavarian Nordic for 20 million doses of IMVAMUNEhttp://www.mva.org/composite-1118.htm 2007-06-06T00:00:001118TopoTarget announces offering circularhttp://www.mva.org/composite-1119.htm 2007-06-06T00:00:001119MVA granted DKK 600.000 to use for information on IMI (in Danish)http://www.mva.org/composite-1122.htm 2007-06-06T00:00:001122TopoTarget has received an approvable letter for Totecthttp://www.mva.org/composite-1121.htm 2007-06-05T00:00:001121Genmab in C20 index (in Danish)http://www.mva.org/composite-1117.htm 2007-06-01T00:00:001117Experienced pharma executive joins ReceptIcon's Board as Chairmanhttp://www.mva.org/composite-1116.htm 2007-05-31T00:00:001116Alligator Bioscience raise 51 MSEK in new share issuehttp://www.mva.org/composite-1126.htm 2007-05-29T00:00:001126Dr Flemming Ørnskov Chairman of Santaris Pharma Boardhttp://www.mva.org/composite-1114.htm 2007-05-29T00:00:001114Preeclampsia diagnostics won the Innovation Prize in Lundhttp://www.mva.org/composite-1115.htm 2007-05-29T00:00:001115Closing dates for NordForsk applicationshttp://www.mva.org/composite-1112.htm 2007-05-25T00:00:001112German doctors enthusiastic about ALK-Abello vaccine (in Danish)http://www.mva.org/composite-1110.htm 2007-05-24T00:00:001110MVA, Lif and LIF close their work on hosting IMI Executive Office in Medicon Valleyhttp://www.mva.org/composite-1113.htm 2007-05-24T00:00:001113Best year for Medicon Valleyhttp://www.mva.org/composite-1100.htm 2007-05-23T00:00:001100New Scientist: The biggest buzz is around Medicon Valleyhttp://www.mva.org/composite-1109.htm 2007-05-23T00:00:001109Launch of the magazine Life Science CLUSTERShttp://www.mva.org/composite-1107.htm 2007-05-23T00:00:001107Network meeting for new businesses in Medicon Valleyhttp://www.mva.org/composite-1105.htm 2007-05-23T00:00:001105MIP and Camurus receive Vinnova co-fundinghttp://www.mva.org/composite-1111.htm 2007-05-23T00:00:001111MVA promoted cancer research and innovation at post-BIO meetinghttp://www.mva.org/composite-1104.htm 2007-05-23T00:00:001104Exiqon stock offering commences on 22 Mayhttp://www.mva.org/composite-1108.htm 2007-05-21T00:00:001108PhaseOneTrials on First North (in Danish)http://www.mva.org/composite-1106.htm 2007-05-16T00:00:001106Medicon Valley biotech attracts British investors (in Danish)http://www.mva.org/composite-1102.htm 2007-05-15T00:00:001102Medicon Valley raising awareness at BioBoston 2007 (in Danish)http://www.mva.org/composite-1101.htm 2007-05-15T00:00:001101UK-Medicon Valley Bioscience Alliance Diabetes Workshophttp://www.mva.org/composite-1103.htm 2007-05-12T00:00:001103PhaseOneTrials goes public on First North (in Danish)http://www.mva.org/composite-1099.htm 2007-05-10T00:00:001099New heavy private venture fund launched (in Danish)http://www.mva.org/composite-1098.htm 2007-05-10T00:00:001098Symphogen granted new allergy patenthttp://www.mva.org/composite-1097.htm 2007-05-08T00:00:001097Camurus to start enrollment in prostate cancer trialhttp://www.mva.org/composite-1096.htm 2007-05-08T00:00:001096Bavarian Nordic and Pharmexa initiates phase I trial of HIV vaccineshttp://www.mva.org/composite-1094.htm 2007-05-02T00:00:001094Novo grants DKK 600 million for basic research (in Danish)http://www.mva.org/composite-1095.htm 2007-05-01T00:00:001095Novo spends DKK 100 million on life science seed programhttp://www.mva.org/composite-1093.htm 2007-05-01T00:00:001093Alligator Bioscience AB launches Findbind methodhttp://www.mva.org/composite-1092.htm 2007-05-01T00:00:001092Osteologix completes enrolment in clinical trialhttp://www.mva.org/composite-1091.htm 2007-04-27T00:00:001091AstraZeneca to Acquire MedImmune Inc (in Danish)http://www.mva.org/composite-1088.htm 2007-04-26T00:00:001088Neurosearch and GSK initiates phase II trials (in Danish)http://www.mva.org/composite-1090.htm 2007-04-26T00:00:001090Novozymes creates a new biopharmaceutical ingredients businesshttp://www.mva.org/composite-1087.htm 2007-04-26T00:00:001087Camarus announces positive phase 1 results with CAM2029http://www.mva.org/composite-1089.htm 2007-04-26T00:00:001089PhaseOneTrials considers IPO on First North (in Danish)http://www.mva.org/composite-1086.htm 2007-04-25T00:00:001086News from Diabetes and Obesity Workshop (in Swedish)http://www.mva.org/composite-1085.htm 2007-04-25T00:00:001085News from Diabetes and Obesity Workshop (in Swedish)http://www.mva.org/composite-1084.htm 2007-04-25T00:00:001084Study Suggests New Avenue on Diabeteshttp://www.mva.org/composite-1078.htm 2007-04-18T00:00:001078U.S. Government acquire 20 million doses of Bavarian Nordic smallpox vaccinehttp://www.mva.org/composite-1083.htm 2007-04-17T00:00:001083Diabody agreement between Pharmexa and Affitechhttp://www.mva.org/composite-1080.htm 2007-04-17T00:00:001080Umetrics 20 yearshttp://www.mva.org/composite-1079.htm 2007-04-17T00:00:001079Lifecycle Pharma A/S annual general meetinghttp://www.mva.org/composite-1077.htm 2007-04-17T00:00:001077SLS Venture ceases their investments in Ultrazonix (in Danish)http://www.mva.org/composite-1076.htm 2007-04-17T00:00:001076The number of Swedish employees in Denmark doubled last year (in Danish)http://www.mva.org/composite-1075.htm 2007-04-17T00:00:001075MVA Editorial no. 04, April 2007http://www.mva.org/composite-1081.htm 2007-04-16T00:00:001081Florian Schönharting: Buck the Danish law of Jantehttp://www.mva.org/composite-1070.htm 2007-04-16T00:00:001070Law gives Danish government control of university research fieldshttp://www.mva.org/composite-1071.htm 2007-04-16T00:00:001071New foundation coordinating the incubators of Lund (in Swedish)http://www.mva.org/composite-1082.htm 2007-04-16T00:00:001082Stina Gestrelius: How to beat USA and Chinahttp://www.mva.org/composite-1067.htm 2007-04-16T00:00:001067Emerging cross border regional innovation systemshttp://www.mva.org/composite-1074.htm 2007-04-16T00:00:001074MVA International Relations Manager to create innovative international networkhttp://www.mva.org/composite-1073.htm 2007-04-13T00:00:001073VinnVinn creates winners through flexibilityhttp://www.mva.org/composite-1072.htm 2007-04-12T00:00:001072TopoTarget acquires Apoxis SA and plans to raise capital through new shareshttp://www.mva.org/composite-1068.htm 2007-04-11T00:00:001068Biogaia signs agreement in USAhttp://www.mva.org/composite-1069.htm 2007-04-11T00:00:001069Zacco in prestigious double win at the annual MIP Global Awardshttp://www.mva.org/composite-1063.htm 2007-04-03T00:00:00106325 million for cancer research in Lund (in Swedish)http://www.mva.org/composite-1064.htm 2007-04-03T00:00:001064New MVA Board of Directors: Executives behind a strong life science region (in Danish)http://www.mva.org/composite-1062.htm 2007-03-31T00:00:00106210 April deadline for registration on World Congress on Inflammationhttp://www.mva.org/composite-2251.htm 2007-03-30T00:00:002251DKK 750 million for strategical research in 2007 (in Danish)http://www.mva.org/composite-1061.htm 2007-03-26T00:00:001061AnaMar Medical changes course (in Danish)http://www.mva.org/composite-1060.htm 2007-03-26T00:00:001060LIDDS gets SEK 40 million for clinical study (in Swedish)http://www.mva.org/composite-1059.htm 2007-03-23T00:00:001059Industrifonden invests one third in Skåne (in Swedish)http://www.mva.org/composite-1058.htm 2007-03-23T00:00:001058TopoTarget executes its licensing option for Zenmab developmenthttp://www.mva.org/composite-1053.htm 2007-03-16T00:00:001053Research breakthrough in cancer (in Danish)http://www.mva.org/composite-1055.htm 2007-03-15T00:00:001055Biotech - how to beat the US and Chinahttp://www.mva.org/composite-1056.htm 2007-03-15T00:00:001056New research in hereditary diseases (in Danish)http://www.mva.org/composite-1057.htm 2007-03-15T00:00:001057Danish stock market ahead (in Danish)http://www.mva.org/composite-1054.htm 2007-03-14T00:00:001054Intelligent biochip to detect airborne microorganismshttp://www.mva.org/composite-1052.htm 2007-03-13T00:00:001052Active Biotech announces positive clinical datahttp://www.mva.org/composite-1051.htm 2007-03-12T00:00:001051Symphogen and Biovitrum enter clinical trialhttp://www.mva.org/composite-1049.htm 2007-03-12T00:00:001049Successful year for clinical trial unit (CTU) in Lundhttp://www.mva.org/composite-1048.htm 2007-03-09T00:00:001048One third of the companies in Medicon Valley are of urological interest (in Danish)http://www.mva.org/composite-1045.htm 2007-03-08T00:00:001045Chemel outsources reagent production to Czech biotech company (in Swedish)http://www.mva.org/composite-1047.htm 2007-03-08T00:00:001047Novo Nordisk and the Chinese Academy of Sciences establish research foundation in Chinahttp://www.mva.org/composite-1044.htm 2007-03-08T00:00:001044Novo Nordisk buys protein purification platformhttp://www.mva.org/composite-1042.htm 2007-03-07T00:00:001042The Danish Agency of Science Technology and Innovation calls for project proposals (in Danish)http://www.mva.org/composite-1041.htm 2007-03-06T00:00:001041Life Science in Silicon Valley - Innovation Center Denmarkhttp://www.mva.org/composite-1038.htm 2007-03-05T00:00:001038New BRIC research: Gene-family regulate stem cellshttp://www.mva.org/composite-1039.htm 2007-02-28T00:00:001039Business Ph.D. provides companies with new knowledge and inspiration (in Danish)http://www.mva.org/composite-1036.htm 2007-02-28T00:00:001036The Swedish Government proposes support for locating the ESS in Lundhttp://www.mva.org/composite-1037.htm 2007-02-28T00:00:001037Danish scientists receive DKK 1,5 million from University of Lund (in Swedish)http://www.mva.org/composite-1035.htm 2007-02-27T00:00:001035CAT Research Park to establish new entrepreneur fundhttp://www.mva.org/composite-1034.htm 2007-02-27T00:00:001034New venture capital fund to attract SEK 200 million (in Swedish)http://www.mva.org/composite-1032.htm 2007-02-27T00:00:001032US President George Bush visited Novozymeshttp://www.mva.org/composite-1033.htm 2007-02-27T00:00:001033Two new markets for Biogaiahttp://www.mva.org/composite-1031.htm 2007-02-26T00:00:001031Camurus to launch proof-of-concept trialhttp://www.mva.org/composite-1030.htm 2007-02-21T00:00:001030Free access to diabetes research toolhttp://www.mva.org/composite-1029.htm 2007-02-19T00:00:001029Malmø hosts transatlantic entrepreneurial event (in Danish)http://www.mva.org/composite-1028.htm 2007-02-16T00:00:001028Skype-investor sets up a foundation for Scandinavian life science (in Danish)http://www.mva.org/composite-1027.htm 2007-02-15T00:00:001027Denmark has a large potential for attracting international researchershttp://www.mva.org/composite-1024.htm 2007-02-15T00:00:001024Zacco acquires the majority in Ipendohttp://www.mva.org/composite-1025.htm 2007-02-15T00:00:001025Deal between Genmab and GSK is official (in Danish)http://www.mva.org/composite-1023.htm 2007-02-14T00:00:001023Advance in prices for Bavarian Nordic (in Danish)http://www.mva.org/composite-1022.htm 2007-02-14T00:00:001022Cambrex Completes Sale of Bio Businesseshttp://www.mva.org/composite-1021.htm 2007-02-14T00:00:001021BioInvent and ThromboGenics receive clinical trial approvalhttp://www.mva.org/composite-1019.htm 2007-02-13T00:00:001019Establish an Oresund Region globalization council (in Danish)http://www.mva.org/composite-1017.htm 2007-02-13T00:00:0010171st ERC call for proposals, EU Seventh Framework programmehttp://www.mva.org/composite-1020.htm 2007-02-13T00:00:001020The British Minister of Science launches UK-Medicon Valley Alliancehttp://www.mva.org/composite-1015.htm 2007-02-12T00:00:001015How to become a successful biotech companyhttp://www.mva.org/composite-1013.htm 2007-02-12T00:00:001013EDITORIAL: Tax incentives encourages biotech growth, MVA Newsletter, February 2007http://www.mva.org/composite-1014.htm 2007-02-12T00:00:001014Three billion in interest of Denmarks innovative capacityhttp://www.mva.org/composite-1016.htm 2007-02-09T00:00:001016Bonesupport signs distribution agreement for the U.S. Markethttp://www.mva.org/composite-1012.htm 2007-02-06T00:00:001012AstraZeneca Acquires Arrow Therapeutics to Broaden Anti-Infective Capabilitieshttp://www.mva.org/composite-1010.htm 2007-02-02T00:00:001010Denmark plans to reduce corporate tax level to 22 per centhttp://www.mva.org/composite-1009.htm 2007-02-02T00:00:001009Founder of Genovis rewarded as Rapidusrookie 2007http://www.mva.org/composite-1011.htm 2007-02-01T00:00:001011Bill Clinton speaks at Novo Nordisk Forumhttp://www.mva.org/composite-1008.htm 2007-01-30T00:00:001008FDA approval for Santaris Pharma cancer drughttp://www.mva.org/composite-1007.htm 2007-01-29T00:00:001007Young scientists receive prices (in Danish)http://www.mva.org/composite-1005.htm 2007-01-26T00:00:001005Top-scientist at University of Copenhagen (in Danish)http://www.mva.org/composite-1006.htm 2007-01-26T00:00:001006New management for Bonesupport (in Swedish)http://www.mva.org/composite-1004.htm 2007-01-24T00:00:001004New hospital might be placed in Ørestaden (in Danish)http://www.mva.org/composite-1001.htm 2007-01-23T00:00:00100112 million SEK for clinical research on Parkinson's disease (in Swedish)http://www.mva.org/composite-1002.htm 2007-01-23T00:00:001002New call for High Technology (in Danish)http://www.mva.org/composite-1000.htm 2007-01-18T00:00:001000Novo Nordisk focuses research and development on therapeutic proteinshttp://www.mva.org/composite-996.htm 2007-01-17T00:00:00996Swedes needed for Danish research (in Swedish)http://www.mva.org/composite-999.htm 2007-01-16T00:00:00999Specimen of urine reveals cancer size (in Danish)http://www.mva.org/composite-998.htm 2007-01-16T00:00:00998Supreme Court forces paradigm shift in patent licensinghttp://www.mva.org/composite-995.htm 2007-01-16T00:00:00995BioInvent and Genentech in commercial collaborationhttp://www.mva.org/composite-994.htm 2007-01-12T00:00:00994Biotech Business Alliance with Japanhttp://www.mva.org/composite-1771.htm 2007-01-11T00:00:001771Medicon Valley Academy and Morrison & Foerster sign Global Law Firm Partnership Agreementhttp://www.mva.org/composite-993.htm 2007-01-10T00:00:00993How to brand Medicon Valleyhttp://www.mva.org/composite-988.htm 2007-01-10T00:00:009882006 a vintage year in Danish biotechhttp://www.mva.org/composite-987.htm 2007-01-10T00:00:00987Nycomed finalizes acquisitionhttp://www.mva.org/composite-991.htm 2007-01-09T00:00:00991Biolin acquires Integration Diagnosticshttp://www.mva.org/composite-990.htm 2007-01-09T00:00:00990Enzyme removes hidden dirthttp://www.mva.org/composite-992.htm 2007-01-09T00:00:00992Surgima moves activities to Copenhagenhttp://www.mva.org/composite-989.htm 2007-01-09T00:00:00989MVA members – great investment potentialhttp://www.mva.org/composite-986.htm 2007-01-08T00:00:00986Bavarian Nordic A/S receives approval to start Phase I/II trials with breast cancer vaccinehttp://www.mva.org/composite-985.htm 2007-01-05T00:00:00985BioInvent and ThromboGenics gets 2 MEUR in EU contribution to ANGIOSTOP (in Swedish)http://www.mva.org/composite-984.htm 2007-01-04T00:00:00984FP7 approved start-up 1. January 2007http://www.mva.org/composite-983.htm 2007-01-04T00:00:00983Biggest university in Scandinavia a reality (in Danish)http://www.mva.org/composite-982.htm 2007-01-04T00:00:00982World's first tablet-based vaccine against grass pollen allergy launchedhttp://www.mva.org/composite-981.htm 2007-01-04T00:00:00981Biogen-Idec in new gigantic Danish investmenthttp://www.mva.org/composite-977.htm 2006-12-22T00:00:009772006: best investment year in biotech (in Danish)http://www.mva.org/composite-978.htm 2006-12-21T00:00:00978Flow of investments into Scanian Corporations (in Danish)http://www.mva.org/composite-973.htm 2006-12-21T00:00:00973Hospital scientists to create growth in Copenhagen (in Danish)http://www.mva.org/composite-974.htm 2006-12-21T00:00:00974How will Øresund look in 2020 (in Danish)http://www.mva.org/composite-972.htm 2006-12-21T00:00:00972Active Biotech conducts guarenteed preferential rights issue for SEK 240 Mhttp://www.mva.org/composite-971.htm 2006-12-20T00:00:009712cureX moves from Copenhagen to Malmø (in Swedish)http://www.mva.org/composite-976.htm 2006-12-20T00:00:00976Record-break deal for Genmabhttp://www.mva.org/composite-970.htm 2006-12-20T00:00:00970New database of alternatives to animal testing onlinehttp://www.mva.org/composite-969.htm 2006-12-18T00:00:00969Danish-Chinese cooperation in Drug Discovery (in Danish)http://www.mva.org/composite-968.htm 2006-12-18T00:00:00968Osteologix initiates phase II clinical Trialhttp://www.mva.org/composite-967.htm 2006-12-18T00:00:00967Collaboration between Symphogen and Meiji (in Danish)http://www.mva.org/composite-966.htm 2006-12-12T00:00:00966Hope for EU-funding in Øresund (in Danish)http://www.mva.org/composite-965.htm 2006-12-11T00:00:00965Højteknologifonden seek projects for funding (in Danish)http://www.mva.org/composite-964.htm 2006-12-08T00:00:00964Genmab announces positive interim datahttp://www.mva.org/composite-963.htm 2006-12-08T00:00:00963Nycomed appoints executive vice presidenthttp://www.mva.org/composite-961.htm 2006-12-08T00:00:00961Novo Nordisk announces major expansion in the UShttp://www.mva.org/composite-962.htm 2006-12-07T00:00:00962Osteologix Initiates Phase II Clinical Trial of Investigational Drug for Osteoporosishttp://www.mva.org/composite-960.htm 2006-12-07T00:00:00960Covalent Group completes merger and changes namehttp://www.mva.org/composite-959.htm 2006-12-07T00:00:00959Section of Clinical Drug Development, Pharmaceutical Society of Denmarkhttp://www.mva.org/composite-2229.htm 2006-11-30T00:00:002229Chempaq ready to enter American market (in Danish)http://www.mva.org/composite-958.htm 2006-11-30T00:00:00958Global distributor to expand sales of MIP Technologies (in Danish)http://www.mva.org/composite-957.htm 2006-11-27T00:00:00957Santaris Pharma awarded Entrepreneur of the Yearhttp://www.mva.org/composite-956.htm 2006-11-24T00:00:00956WeAidU in Ideon gets new owner (in Swedish)http://www.mva.org/composite-954.htm 2006-11-24T00:00:00954Alumni opens branch in Copenhagen (in Danish)http://www.mva.org/composite-955.htm 2006-11-24T00:00:00955Östersjöstiftelsen invests in Lund-based companies (in Swedish)http://www.mva.org/composite-953.htm 2006-11-23T00:00:00953Ludesi wins prestigious contracthttp://www.mva.org/composite-952.htm 2006-11-23T00:00:00952Gardasil wins biomedical award (in Swedish)http://www.mva.org/composite-951.htm 2006-11-23T00:00:00951Vinnova program lives on - millions for Active Biotech and DuoCort (in Swedish)http://www.mva.org/composite-950.htm 2006-11-22T00:00:00950Information meeting: Biotechnica 2007 in Hannover (in Danish)http://www.mva.org/composite-2222.htm 2006-11-22T00:00:002222Danish-Swedish network strengthens diabetes research(in Danish)http://www.mva.org/composite-949.htm 2006-11-22T00:00:00949SixSteps Announces the GCP Validated Release of ™Capish Clinical 2.2http://www.mva.org/composite-947.htm 2006-11-21T00:00:00947Ferring in Malmø saved by Chinese company (in Swedish)http://www.mva.org/composite-948.htm 2006-11-21T00:00:00948Knowledge Management Seminar in Ørestad on the 6th of Decemberhttp://www.mva.org/composite-1773.htm 2006-11-20T00:00:001773Perfect timing for Anamar financehttp://www.mva.org/composite-946.htm 2006-11-20T00:00:00946Lund research develops MedicPen products (in Swedish)http://www.mva.org/composite-945.htm 2006-11-20T00:00:00945Swedes very intersted in working in Denmark (in Danish)http://www.mva.org/composite-944.htm 2006-11-17T00:00:00944TopoTarget establishes TopoTarget USA, Inc. and employs experienced marketeer as Presidenthttp://www.mva.org/composite-943.htm 2006-11-16T00:00:00943TopoTarget and CuraGen Announce Updated PXD101 Phase Ib Resultshttp://www.mva.org/composite-942.htm 2006-11-16T00:00:00942Region Skåne and Region Hovedstaden (Copenhagen) in collaboration for public procurement and purchase to 24 hospitals (in Swedish)http://www.mva.org/composite-941.htm 2006-11-13T00:00:00941New Danish biotech company (in Danish)http://www.mva.org/composite-940.htm 2006-11-13T00:00:00940Bavarian Nordic A/S – Interim Report as of 30 September 2006http://www.mva.org/composite-939.htm 2006-11-10T00:00:00939Maxygen's Next-Generation Interferon Alpha Enters Phase Ia Clinical Trialhttp://www.mva.org/composite-937.htm 2006-11-10T00:00:00937Roche presents positive preclinical data on Genmab antibodyhttp://www.mva.org/composite-938.htm 2006-11-10T00:00:00938University of Copenhagen acheives new centres for basic research (in Danish)http://www.mva.org/composite-936.htm 2006-11-09T00:00:00936Evolva doubles staff after receiving million US$ grant (in Danish)http://www.mva.org/composite-935.htm 2006-11-09T00:00:00935University of Copenhagen publishes new strategy (in Danish)http://www.mva.org/composite-932.htm 2006-11-07T00:00:00932EU grant to analysis of cancer tissuehttp://www.mva.org/composite-934.htm 2006-11-06T00:00:00934New Øresund Jobsite (in Danish)http://www.mva.org/composite-930.htm 2006-11-06T00:00:00930Danish government invests in innovation and entrepreneurship (in Danish)http://www.mva.org/composite-931.htm 2006-11-06T00:00:00931MVA Newsletter no 10, October 2006http://www.mva.org/composite-929.htm 2006-11-02T00:00:00929US Institute of Medicine proposes special labelling and 5 year post marketing follow-up of new medicines (in Swedish with US link)http://www.mva.org/composite-928.htm 2006-11-02T00:00:00928Novozymes: group financial statement for the first nine months of 2006http://www.mva.org/composite-927.htm 2006-10-30T00:00:00927Swedish biotech company picks up pace (in Swedish)http://www.mva.org/composite-926.htm 2006-10-30T00:00:00926Strong financing round for Danish Action Pharma A/Shttp://www.mva.org/composite-925.htm 2006-10-26T00:00:00925Swedish government skips Vinnova project (in Swedish)http://www.mva.org/composite-924.htm 2006-10-26T00:00:00924Danish biotechcompany negotiates for 300m USD dealhttp://www.mva.org/composite-923.htm 2006-10-25T00:00:00923Half a billion euros to international research collaborationshttp://www.mva.org/composite-920.htm 2006-10-24T00:00:00920Cobis the foundation for future biotech (in Swedish)http://www.mva.org/composite-922.htm 2006-10-23T00:00:00922Alligator and AlgoNomics business-partners (in Danish)http://www.mva.org/composite-921.htm 2006-10-23T00:00:00921Oresund a growth center (in Danish)http://www.mva.org/composite-919.htm 2006-10-23T00:00:00919IT as a driver for change in the life sciences industryhttp://www.mva.org/composite-2210.htm 2006-10-19T00:00:002210Danish biotech acquisition worth EUR 1.5 billion may be on its wayhttp://www.mva.org/composite-918.htm 2006-10-18T00:00:00918Medeon in Malmø grows (in Danish)http://www.mva.org/composite-917.htm 2006-10-16T00:00:00917Claus Braestrup, CEO of Lundbeck, appointed to Santaris Pharma Boardhttp://www.mva.org/composite-916.htm 2006-10-12T00:00:00916Increasing commercialisation at the Danish universitieshttp://www.mva.org/composite-915.htm 2006-10-12T00:00:00915Genzyme proposes to acquire AnorMEDhttp://www.mva.org/composite-914.htm 2006-10-12T00:00:00914Investment survey reveals optimism about biotechnology sectorhttp://www.mva.org/composite-912.htm 2006-10-09T00:00:00912Action Pharma towards IPO (in Danish)http://www.mva.org/composite-913.htm 2006-10-09T00:00:00913University of Copenhagen best in Scandinaviahttp://www.mva.org/composite-911.htm 2006-10-06T00:00:00911Genzyme Receives European Approval for Synvischttp://www.mva.org/composite-910.htm 2006-10-06T00:00:00910New pharmaceutical candidate in Lundbeck’s pipelinehttp://www.mva.org/composite-909.htm 2006-10-06T00:00:00909TopoTarget’s launches antidote for accidental tissue exposure during chemotherapyhttp://www.mva.org/composite-908.htm 2006-10-06T00:00:00908Sydsvenskan: Swedish government must prioritise Øresund (in Swedish)http://www.mva.org/composite-907.htm 2006-10-05T00:00:00907Danish government approves university-merger (in Danish)http://www.mva.org/composite-903.htm 2006-10-05T00:00:00903Venturecapital-conference attracts 20 Øresundcompanies (in Danish)http://www.mva.org/composite-904.htm 2006-10-05T00:00:00904KVL heads huge EU research project (in Danish)http://www.mva.org/composite-905.htm 2006-10-05T00:00:00905Workshop on ageing, longevity and health in Copenhagen (in Danish)http://www.mva.org/composite-902.htm 2006-10-03T00:00:00902The Danish Agency of Science Technology and Innovation opens to applications for EU-projects (in Danish)http://www.mva.org/composite-901.htm 2006-10-02T00:00:00901Companies and public scientists in exciting co-operation (in Danish)http://www.mva.org/composite-900.htm 2006-10-02T00:00:00900MatchMaking 2006http://www.mva.org/composite-2204.htm 2006-10-02T00:00:002204PhaseOneTrials initiates a ‘First-in-Man’ studyhttp://www.mva.org/composite-899.htm 2006-10-02T00:00:00899Medicon becomes Cyncron (in Swedish)http://www.mva.org/composite-897.htm 2006-09-28T00:00:00897Genovis presents new technology (in Swedish)http://www.mva.org/composite-896.htm 2006-09-28T00:00:00896SCANBALT LAUNCHES YELLOW PAGEShttp://www.mva.org/composite-895.htm 2006-09-25T00:00:00895IMI the biggest development within medical science for yearshttp://www.mva.org/composite-894.htm 2006-09-23T00:00:00894Food and drug administration (FDA) seminar for the biopharma industryhttp://www.mva.org/composite-2201.htm 2006-09-22T00:00:002201MVA BioTech Forum Newsletter no. 09 September 2006http://www.mva.org/composite-893.htm 2006-09-22T00:00:00893Nycomed aquires ALTANA Pharmahttp://www.mva.org/composite-892.htm 2006-09-22T00:00:00892InnovationsKapital invests 25 million SEK in Ludesi (in Danish)http://www.mva.org/composite-891.htm 2006-09-21T00:00:00891Fåhraeus and Mårtensson first Swedes in Vækstfonden (in Danish)http://www.mva.org/composite-890.htm 2006-09-19T00:00:00890Danish university merge gives potential lift to the Medicon Valley region (in Danish)http://www.mva.org/composite-889.htm 2006-09-18T00:00:00889ProstaLund plans extensive restructure (in Swedish)http://www.mva.org/composite-888.htm 2006-09-15T00:00:00888Medicon Valley Academy to nurse project with support from Vinnova and the Højteknologifond (in Danish)http://www.mva.org/composite-887.htm 2006-09-15T00:00:00887Novo Nordisk World Tour to raise awareness on diabeteshttp://www.mva.org/composite-885.htm 2006-09-14T00:00:0088510 ambassadors to bioclusters to exchange with MVA – Japan first goal (in Danish)http://www.mva.org/composite-886.htm 2006-09-14T00:00:00886Exiqon Expands in US; Sales Headquarters Establishedhttp://www.mva.org/composite-884.htm 2006-09-13T00:00:00884Symphogen issued patent covering SYMPRESS™ technology for manufacturing recombinant polyclonal antibodieshttp://www.mva.org/composite-883.htm 2006-09-12T00:00:00883Entrepreneurship Academy in the Øresund regionhttp://www.mva.org/composite-882.htm 2006-09-11T00:00:00882New Chairman at MIP Technologieshttp://www.mva.org/composite-881.htm 2006-09-11T00:00:00881Strengthened QM & Regulatory Capabilities at Mediconhttp://www.mva.org/composite-880.htm 2006-09-11T00:00:00880New investments in biotech (in Danish)http://www.mva.org/composite-879.htm 2006-09-08T00:00:00879Novo Ventures invests in Biotech (in Danish)http://www.mva.org/composite-878.htm 2006-09-08T00:00:00878Natimmune buys Hamlet Pharma (In Danish)http://www.mva.org/composite-874.htm 2006-09-08T00:00:00874Investors believe in Danish biotech (in Danish)http://www.mva.org/composite-877.htm 2006-09-07T00:00:00877Zealand Pharma raises capital for development of drugs forhttp://www.mva.org/composite-875.htm 2006-09-07T00:00:00875Novozymes no. 1 for sustainabilityhttp://www.mva.org/composite-873.htm 2006-09-07T00:00:00873Maxygen Initiates Phase I Clinical Trial for Maxy-G34http://www.mva.org/composite-876.htm 2006-09-06T00:00:00876Genovis products ready for release at the BioTech Forum (In Swedish)http://www.mva.org/composite-871.htm 2006-09-05T00:00:00871Gastrotech Pharma skips IPO (in Danish)http://www.mva.org/composite-872.htm 2006-09-05T00:00:00872Hamlet efficiently treats skin Papillomas (In Swedish)http://www.mva.org/composite-868.htm 2006-09-04T00:00:00868Acquisition of Carlsson Researchhttp://www.mva.org/composite-870.htm 2006-09-04T00:00:00870ReceptIcon appoints new CEOhttp://www.mva.org/composite-869.htm 2006-09-04T00:00:00869MVA newsletter no 8, August 2006http://www.mva.org/composite-2368.htm 2006-08-24T00:00:002368Press release: MVA comments on CBS report (in Danish)http://www.mva.org/composite-1261.htm 2006-08-24T00:00:001261MVA newsletter, no.7, August 2006 - MVA at BioTech Forum 2006http://www.mva.org/composite-2367.htm 2006-08-22T00:00:002367Denmark must retain their Swedish medical students locally (in Swedish)http://www.mva.org/composite-865.htm 2006-08-19T00:00:00865Pharmexa discontinues Phase II of breast cancer vaccinehttp://www.mva.org/composite-864.htm 2006-08-15T00:00:00864International Food & Health Innovation Conference 2006, 25 - 27 October 2006 in Malmö - Deadline for low fee: 16 August !http://www.mva.org/composite-2192.htm 2006-08-11T00:00:002192ACADIA Pharmaceuticals Reports Second Quarter 2006 Financial Resultshttp://www.mva.org/composite-860.htm 2006-08-11T00:00:00860Novozymes financial statement for first half of 2006http://www.mva.org/composite-861.htm 2006-08-10T00:00:00861Medicon Valley Academy maps biotech boards (in Danish)http://www.mva.org/composite-859.htm 2006-08-09T00:00:00859Swedish media reacts against Swedens “free-riding” on Danish medical educationhttp://www.mva.org/composite-858.htm 2006-08-08T00:00:00858Danish scientist chairman of European research council (in Danish)http://www.mva.org/composite-857.htm 2006-08-08T00:00:00857Lack of Danish Biotech chairmen and board members (in Danish)http://www.mva.org/composite-856.htm 2006-08-07T00:00:00856Conference 19 September 2006 - A globalised supply chainhttp://www.mva.org/composite-855.htm 2006-08-07T00:00:00855FP7 workshop - Helping SMEs & Researchers prepare for FP7 European R&D projectshttp://www.mva.org/composite-2181.htm 2006-08-07T00:00:002181Third breast cancer gene identifiedhttp://www.mva.org/composite-854.htm 2006-08-04T00:00:00854Genmab named finalist for European biotechnical award 2006http://www.mva.org/composite-853.htm 2006-08-04T00:00:00853Novo Nordisk receives approval in the EU for use of NovoRapid in pregnancyhttp://www.mva.org/composite-852.htm 2006-08-02T00:00:00852Enzon and Santaris Pharma enter into Global Collaboration to Develop Novel Cancer Therapeuticshttp://www.mva.org/composite-851.htm 2006-07-28T00:00:00851Genzyme Receives Approval for Additional Manufacturing at Ireland Planthttp://www.mva.org/composite-850.htm 2006-07-27T00:00:00850Synarc to Combine with Center for Clinical and Basic Researchhttp://www.mva.org/composite-849.htm 2006-07-26T00:00:00849EU financed stem cell research still possible (in Swedish)http://www.mva.org/composite-848.htm 2006-07-25T00:00:00848Swedish government invests 175 million sek in biotech- and medical research (in Swedish)http://www.mva.org/composite-847.htm 2006-07-14T00:00:00847Öresund Academy of Entrepreneurship gets national and regional support from Denmark and Sweden (in Swedish)http://www.mva.org/composite-846.htm 2006-07-14T00:00:00846BioInvent updates status within the HIV projecthttp://www.mva.org/composite-844.htm 2006-07-13T00:00:00844Cyclotron Meeting 29 August 2006 (in Danish)http://www.mva.org/composite-2180.htm 2006-07-12T00:00:002180Medicon Valley Academy and Norgenta North German Life Science Agency agree on cooperation in two projectshttp://www.mva.org/composite-843.htm 2006-07-10T00:00:00843BoneSupport™ finalist in patent strategy competitionhttp://www.mva.org/composite-842.htm 2006-07-07T00:00:00842Drug companies compete in market for new diabetes treatmentshttp://www.mva.org/composite-841.htm 2006-07-06T00:00:00841Exiqon announces new global distribution pointshttp://www.mva.org/composite-840.htm 2006-07-06T00:00:00840VersaMatrix A/S launches Versaffin™ for affinity resin-mediated bioseparationhttp://www.mva.org/composite-839.htm 2006-07-04T00:00:00839Medicine- and biotechindustry needs employees (in Danish)http://www.mva.org/composite-838.htm 2006-07-03T00:00:00838Nycomed acquires Romanian pharmaceutical companyhttp://www.mva.org/composite-836.htm 2006-07-03T00:00:00836Newsletter Medicon Valley Academy June 2006http://www.mva.org/composite-837.htm 2006-07-02T00:00:00837Research from Lund won the Linné-funding (in Swedish)http://www.mva.org/composite-835.htm 2006-06-30T00:00:00835Gastrotech Pharma most promising biotech companyhttp://www.mva.org/composite-834.htm 2006-06-30T00:00:00834Battle for EU-billions to Medicon Valley (in Danish)http://www.mva.org/composite-832.htm 2006-06-29T00:00:00832Battle for new research-institute (in Danish)http://www.mva.org/composite-833.htm 2006-06-29T00:00:00833The Oresunds-region receives top grade from OECD (in Danish)http://www.mva.org/composite-831.htm 2006-06-27T00:00:00831Deadline of application for grants to Danish scientific research in 2007 (in Danish)http://www.mva.org/composite-830.htm 2006-06-27T00:00:00830Fogh Rasmussens Oresundsvision (in Swedish)http://www.mva.org/composite-829.htm 2006-06-26T00:00:00829Hard-working nano-scientists in the Oresundsregion (in Swedish)http://www.mva.org/composite-828.htm 2006-06-26T00:00:00828Medicon A/S opens its second office in Swedenhttp://www.mva.org/composite-826.htm 2006-06-23T00:00:00826Denmark in need of Swedish specialists (in Swedish)http://www.mva.org/composite-827.htm 2006-06-23T00:00:00827Danish University merge is welcomed (in Danish)http://www.mva.org/composite-825.htm 2006-06-23T00:00:00825Promising Danish university merge (in Danish)http://www.mva.org/composite-824.htm 2006-06-21T00:00:00824Swedish technical medical research in trouble (in Swedish)http://www.mva.org/composite-823.htm 2006-06-21T00:00:00823TopoTarget and CuraGen announce initiation of phase II clinical trial with PXD101 (in Danish)http://www.mva.org/composite-822.htm 2006-06-20T00:00:00822Presentation in Dundee 16 June 2006 by Mr. Stig Jørgensen, Managing Director Medicon Valley Academyhttp://www.mva.org/composite-820.htm 2006-06-19T00:00:00820Hottest potential in Medicon Valleyhttp://www.mva.org/composite-821.htm 2006-06-19T00:00:00821New chairman of the board in Phase One Trial (in Danish)http://www.mva.org/composite-819.htm 2006-06-16T00:00:00819Biotech-fund under pressure (in Danish)http://www.mva.org/composite-818.htm 2006-06-16T00:00:00818TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase I Clinical Trial of PXD101 and Retinoic Acidhttp://www.mva.org/composite-817.htm 2006-06-15T00:00:00817Gastrotech Pharma uses Strictly Financing award for new investmentround (in Swedish)http://www.mva.org/composite-816.htm 2006-06-14T00:00:00816Life sciences partnering event between China and Europehttp://www.mva.org/composite-1765.htm 2006-06-13T00:00:001765Novozymes acquires Delta Biotechnology Ltdhttp://www.mva.org/composite-815.htm 2006-06-13T00:00:00815Very profitable for medico and biotech companies to invest in the Oresund Region (in Danish)http://www.mva.org/composite-814.htm 2006-06-13T00:00:00814Medico firm from Oresund in the lead of Scandinavian US-promotion (in Danish)http://www.mva.org/composite-813.htm 2006-06-12T00:00:00813Strictly Financing appointed Gastrotech Pharma as the most promising biotech company in Medicon Valley (in Danish)http://www.mva.org/composite-810.htm 2006-06-09T00:00:00810Summary of AstraZeneca's strategyhttp://www.mva.org/composite-811.htm 2006-06-08T00:00:00811Successful issue for Capio (in English)http://www.mva.org/composite-808.htm 2006-06-06T00:00:00808Swedish biotech companies in Strictly Financing (in Swedish)http://www.mva.org/composite-807.htm 2006-06-02T00:00:00807Technical medical science receives 75 million sek.(in Swedish)http://www.mva.org/composite-805.htm 2006-06-02T00:00:00805How Cancer cells stay forever young (in english)http://www.mva.org/composite-804.htm 2006-06-01T00:00:008047TM Pharma acquires CareX SA (in English)http://www.mva.org/composite-806.htm 2006-06-01T00:00:00806Swedish-Danish co-operation pays (in Swedish)http://www.mva.org/composite-802.htm 2006-05-31T00:00:00802Young scientists awarded (in English)http://www.mva.org/composite-803.htm 2006-05-31T00:00:00803AstraZeneca announces $ 100 million r&d investment in China (in English)http://www.mva.org/composite-800.htm 2006-05-30T00:00:00800BioInvent reports the result from the clinical study in HIV (in English)http://www.mva.org/composite-801.htm 2006-05-30T00:00:00801DKK 30 million to genome science project (in Danish)http://www.mva.org/composite-798.htm 2006-05-24T00:00:00798EUR 73 billion for Research and Technology Projectshttp://www.mva.org/composite-799.htm 2006-05-24T00:00:00799Oresund role model in cancer treatment (in Danish)http://www.mva.org/composite-797.htm 2006-05-24T00:00:00797Funding for applications for EU-projects (in Danish)http://www.mva.org/composite-795.htm 2006-05-23T00:00:00795Curalogic A/S announces offering circular and IPO (in English)http://www.mva.org/composite-796.htm 2006-05-23T00:00:00796Danish biotech company prepares IPO (Initial Public Offering) (in Danish)http://www.mva.org/composite-793.htm 2006-05-22T00:00:00793TopoTarget finalises purchase of BioImage compounds (in Danish)http://www.mva.org/composite-794.htm 2006-05-22T00:00:00794"Top of Biomarkers" Symposiumhttp://www.mva.org/composite-1774.htm 2006-05-19T00:00:001774Win € 25.000 for a good idea (in English)http://www.mva.org/composite-792.htm 2006-05-19T00:00:00792Genzyme releases tests for acute Myelogenous Leukemia (in English)http://www.mva.org/composite-790.htm 2006-05-19T00:00:00790Research budget agreed - FP7 up by Euro 300 million (in English)http://www.mva.org/composite-788.htm 2006-05-18T00:00:00788Danish healthcare-industry needs Sweden (in Danish)http://www.mva.org/composite-787.htm 2006-05-17T00:00:00787Danish investment in Celltrix (in Swedish)http://www.mva.org/composite-786.htm 2006-05-17T00:00:00786Europe needs modernised universities, says European Commission (in English)http://www.mva.org/composite-783.htm 2006-05-16T00:00:00783Nycomed first quarter results 2006 (in English)http://www.mva.org/composite-782.htm 2006-05-15T00:00:00782ScanBalt Intellectual Property training seminarhttp://www.mva.org/composite-2155.htm 2006-05-15T00:00:002155Award to cancer scientist (in Danish)http://www.mva.org/composite-779.htm 2006-05-11T00:00:00779Denmark welcomes Swedish workers (in Danish)http://www.mva.org/composite-780.htm 2006-05-11T00:00:00780Novo A/S gets surplus from biotech (in Danish)http://www.mva.org/composite-778.htm 2006-05-10T00:00:00778When ideas become reality (in Swedish)http://www.mva.org/composite-777.htm 2006-05-10T00:00:00777Swedish program to strengthen medical- and biotec- industry (in Swedish)http://www.mva.org/composite-776.htm 2006-05-09T00:00:00776AstraZeneca Discontinues Development of GALIDA TM (in English)http://www.mva.org/composite-775.htm 2006-05-09T00:00:00775Bavarian Nordic Strengthens Investor Relations Function (in English)http://www.mva.org/composite-774.htm 2006-05-09T00:00:00774ACADIA Pharmaceuticals Announces First Quarter Financial Results(in English)http://www.mva.org/composite-771.htm 2006-05-05T00:00:00771European Biotech a possible world leader(in Swedish)http://www.mva.org/composite-768.htm 2006-05-04T00:00:00768Press Release: Strictly Financinghttp://www.mva.org/composite-1260.htm 2006-05-03T00:00:001260Need for safer test methods (in Swedish)http://www.mva.org/composite-769.htm 2006-05-03T00:00:00769Den danske regering bakker op om nye EU-regler om funktionelle fødevarer.http://www.mva.org/composite-770.htm 2006-05-03T00:00:00770Positive results from BioGaia(in English)http://www.mva.org/composite-767.htm 2006-05-03T00:00:00767Denmark in European biotech top three(in Danish)http://www.mva.org/composite-766.htm 2006-05-03T00:00:00766Swedish praise to Danish biotec (in Danish)http://www.mva.org/composite-765.htm 2006-05-01T00:00:00765Denmark and Japan in science-coorporation (in Danish)http://www.mva.org/composite-764.htm 2006-04-25T00:00:00764Dutch establishment in Medicon Valley (in English)http://www.mva.org/composite-763.htm 2006-04-24T00:00:00763ACADIA Pharmaceuticals Announces Positive Clinical Trial Results (in English)http://www.mva.org/composite-762.htm 2006-04-24T00:00:00762Genzyme Reports Financial Results for the First Quarter of 2006(in English)http://www.mva.org/composite-761.htm 2006-04-24T00:00:00761TGN1412 episode Calls for Change in Drug Trials (in English)http://www.mva.org/composite-760.htm 2006-04-19T00:00:00760Bioethanol high on the agenda (in English)http://www.mva.org/composite-759.htm 2006-04-19T00:00:00759TopoTarget application in fast lane (in Danish)http://www.mva.org/composite-758.htm 2006-04-12T00:00:00758Innate Pharma and Novo Nordisk announce strategic partnership (in English)http://www.mva.org/composite-757.htm 2006-04-12T00:00:00757Jan Leschly: Research and discovery essential for biotec-industry (in Danish)http://www.mva.org/composite-756.htm 2006-04-11T00:00:00756Genzyme Launches Initiative To Assist the Development of Treatments for Neglected Diseases (in English)http://www.mva.org/composite-754.htm 2006-04-11T00:00:00754Degarelix, a novel GnRH blocker from Ferring, moves into phase III (in English)http://www.mva.org/composite-755.htm 2006-04-11T00:00:00755Prosthetic cancer in focus for clinical studies of SpectraCure (in Swedish)http://www.mva.org/composite-752.htm 2006-04-10T00:00:00752New president in Trial Form Support AB (in Swedish)http://www.mva.org/composite-753.htm 2006-04-10T00:00:00753Danish universities announces potential merge partners (in Danish)http://www.mva.org/composite-751.htm 2006-04-07T00:00:00751New Chairman in MedCoast Scandinavia (in English)http://www.mva.org/composite-750.htm 2006-04-05T00:00:00750Region Hovedstaden focus on one growth forum (in Danish)http://www.m